Clinical Trial Update: mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating mFOLFIRINOX with or without stereotactic body radiotherapy for locally advanced, non-resectable pancreatic adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• mFOLFIRINOX (modified FOLFIRINOX regimen) (modified FOLFIRINOX regimen)

Snippet

Sponsor: Asan Medical Center | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable | Phase 2 | Status: ACTIVE_NOT_RECRUITING